rs522776

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001166114.2(PNPLA6):​c.2547G>A​(p.Ser849Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0282 in 1,614,008 control chromosomes in the GnomAD database, including 776 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.032 ( 94 hom., cov: 32)
Exomes 𝑓: 0.028 ( 682 hom. )

Consequence

PNPLA6
NM_001166114.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.52

Publications

8 publications found
Variant links:
Genes affected
PNPLA6 (HGNC:16268): (patatin like phospholipase domain containing 6) This gene encodes a phospholipase that deacetylates intracellular phosphatidylcholine to produce glycerophosphocholine. It is thought to function in neurite outgrowth and process elongation during neuronal differentiation. The protein is anchored to the cytoplasmic face of the endoplasmic reticulum in both neurons and non-neuronal cells. Mutations in this gene result in autosomal recessive spastic paraplegia, and the protein is the target for neurodegeneration induced by organophosphorus compounds and chemical warfare agents. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
PNPLA6 Gene-Disease associations (from GenCC):
  • ataxia-hypogonadism-choroidal dystrophy syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • PNPLA6-related spastic paraplegia with or without ataxia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 39
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cerebellar ataxia-hypogonadism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Laurence-Moon syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • trichomegaly-retina pigmentary degeneration-dwarfism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-7554636-G-A is Benign according to our data. Variant chr19-7554636-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 383988.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.52 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0806 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001166114.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNPLA6
NM_001166114.2
MANE Select
c.2547G>Ap.Ser849Ser
synonymous
Exon 21 of 32NP_001159586.1
PNPLA6
NM_001166111.2
c.2577G>Ap.Ser859Ser
synonymous
Exon 23 of 34NP_001159583.1
PNPLA6
NM_001166113.1
c.2433G>Ap.Ser811Ser
synonymous
Exon 24 of 35NP_001159585.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNPLA6
ENST00000600737.6
TSL:1 MANE Select
c.2547G>Ap.Ser849Ser
synonymous
Exon 21 of 32ENSP00000473211.1
PNPLA6
ENST00000221249.10
TSL:1
c.2433G>Ap.Ser811Ser
synonymous
Exon 24 of 35ENSP00000221249.5
PNPLA6
ENST00000450331.7
TSL:1
c.2433G>Ap.Ser811Ser
synonymous
Exon 24 of 35ENSP00000394348.2

Frequencies

GnomAD3 genomes
AF:
0.0319
AC:
4857
AN:
152104
Hom.:
95
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0363
Gnomad AMI
AF:
0.0428
Gnomad AMR
AF:
0.0408
Gnomad ASJ
AF:
0.0727
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0106
Gnomad FIN
AF:
0.0249
Gnomad MID
AF:
0.130
Gnomad NFE
AF:
0.0291
Gnomad OTH
AF:
0.0516
GnomAD2 exomes
AF:
0.0269
AC:
6746
AN:
250870
AF XY:
0.0265
show subpopulations
Gnomad AFR exome
AF:
0.0345
Gnomad AMR exome
AF:
0.0246
Gnomad ASJ exome
AF:
0.0725
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0227
Gnomad NFE exome
AF:
0.0314
Gnomad OTH exome
AF:
0.0364
GnomAD4 exome
AF:
0.0278
AC:
40658
AN:
1461786
Hom.:
682
Cov.:
35
AF XY:
0.0277
AC XY:
20125
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.0373
AC:
1248
AN:
33480
American (AMR)
AF:
0.0263
AC:
1174
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0701
AC:
1832
AN:
26134
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0112
AC:
967
AN:
86258
European-Finnish (FIN)
AF:
0.0225
AC:
1199
AN:
53332
Middle Eastern (MID)
AF:
0.0869
AC:
501
AN:
5768
European-Non Finnish (NFE)
AF:
0.0285
AC:
31731
AN:
1111996
Other (OTH)
AF:
0.0332
AC:
2004
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
2415
4829
7244
9658
12073
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1164
2328
3492
4656
5820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0319
AC:
4863
AN:
152222
Hom.:
94
Cov.:
32
AF XY:
0.0314
AC XY:
2339
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0365
AC:
1515
AN:
41526
American (AMR)
AF:
0.0407
AC:
623
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0727
AC:
252
AN:
3468
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5162
South Asian (SAS)
AF:
0.0106
AC:
51
AN:
4820
European-Finnish (FIN)
AF:
0.0249
AC:
264
AN:
10618
Middle Eastern (MID)
AF:
0.119
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
0.0290
AC:
1975
AN:
68004
Other (OTH)
AF:
0.0510
AC:
108
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
232
463
695
926
1158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0312
Hom.:
64
Bravo
AF:
0.0340
Asia WGS
AF:
0.0120
AC:
41
AN:
3478
EpiCase
AF:
0.0333
EpiControl
AF:
0.0313

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hereditary spastic paraplegia 39 (2)
-
-
2
not specified (2)
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.5
DANN
Benign
0.54
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs522776; hg19: chr19-7619522; COSMIC: COSV55385973; COSMIC: COSV55385973; API